Monte Rosa Therapeutics
GLUE
#7469
Rank
C$0.43 B
Marketcap
$6.85
Share price
-2.17%
Change (1 day)
-10.79%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2023 (TTM): -$3.47

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.55. In 2022 the company made an earnings per share (EPS) of -$3.17 an increase over its 2021 EPS that were of -$6.71.

EPS history for Monte Rosa Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.479.48%
2022-$3.17-52.81%
2021-$6.71193.97%
2020-$2.28